Page 7 - Software Precertification Pilot Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Software precertification pilot program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Software Precertification Pilot Program Today - Breaking & Trending Today

Pear Therapeutics and Prescryptive Health Announce Formulary Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for the Treatment of Substance and Opioid Use Disorders


Pear Therapeutics and Prescryptive Health Announce Formulary Coverage for Prescription Digital Therapeutics reSET® & reSET-O® for the Treatment of Substance and Opioid Use Disorders
By
Staff
2 seconds ago
Prescryptive Health, a health intelligence platform focused on improving the prescription drug market and the pharmacy experience, teams with Pear to make innovative prescription digital therapeutics (PDTs) accessible to its members in recovery.
Prescryptive Health will offer and administer Pear’s reSET® and reSET-O® through its digital platform as a covered standard pharmacy benefit for people with substance use disorder or opioid use disorder.
BOSTON & SAN FRANCISCO & REDMOND, Wash.–(BUSINESS WIRE)–Pear Therapeutics, Inc. and Prescryptive Health today announced that Prescryptive, the first health intelligence platform, will offer and administer benefit coverage for reSET® and reSET-O®, the first two prescription digital therapeutics (PDTs) ....

Keely Boyer , Ba Fulton Velez , Karren Williams , Robert Gerwien , Weijia Wang , Kirstin Gatchalian , Warrenk Bickel , Yuria Maricich , Chris Blackley , Charles Ruetsch Kathryn Anastassopoulos , Bruce Imbert , Benjamin Parcher , Laura Kauffman , Xiaorui Xiong , Corey Mccann , Hilaryf Luderer , Lisaa Marsch , Stephen Braun , Sam Colman , Nicole Gellings Lowe , Fultonf Velez , Alice Kuo , Prescryptive Health , Journal Of Current Medical Research , Drug Administration , Current Medical Research ,

Pear Therapeutics Announces Second Closing of Series D Financing


Company adds a leading national Integrated Delivery Network (IDN) as a strategic investor.
The financing supports Pear’s continued efforts to expand patient access for its portfolio of Prescription Digital Therapeutics (PDTs), including reSET®, reSET-O® and Somryst® treating addiction and insomnia conditions, respectively.
BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–Pear Therapeutics, Inc., (“Pear” or the “Company”) today announced the second closing of its Series D financing. The second closing included a leading national Integrated Delivery Network (IDN) as a new strategic investor. The national IDN is investing $20 million, bringing the total Series D investment to $100 million.
“Pear is pleased to add one of America’s leading health care providers and health plans to our distinguished list of investors as we continue to expand patient access to our FDA-authorized digital therapeutics,” said Corey McCann, M.D., Ph.D., President and CEO of Pear Ther ....

United States , Keely Boyer , Ba Fulton Velez , Karren Williams , Robert Gerwien , Weijia Wang , Yuria Maricich , Charles Ruetsch Kathryn Anastassopoulos , Bruce Imbert , Laura Kauffman , Xiaorui Xiong , Corey Mccann , Stephen Braun , Hilaryf Luderer , Sam Colman , Alice Kuo , Nicole Gellings Lowe , Fultonf Velez , Health Care Provider , Journal Of Current Medical Research , Mental Health Services Administration , Expert Review Of Pharmacoeconomics Outcomes Research , Pear Therapeutics Inc , Delivery Network , Software Precertification Pilot Program , Integrated Delivery Network ,

etectRx Announces Agreement to Advance Digital Sensors for Medication Adherence in Combination with Prescription Digital Therapeutics


etectRx Announces Agreement to Advance Digital Sensors for Medication Adherence in Combination with Prescription Digital Therapeutics
News provided by
Share this article
Share this article
GAINESVILLE, Fla., Jan. 14, 2021 /PRNewswire/  Digital health company, etectRx, Inc., announced today that it has entered into an agreement with Pear Therapeutics, Inc. to develop up to two product candidates in the Central Nervous System (CNS) space combining Prescription Digital Therapeutics (PDTs) and adherence sensors. The collaboration is the first of its kind to explore the use of digital pill solutions with PDTs. 
This collaboration between etectRx and Pear Therapeutics comes at a critical time for the mental health field, an area that is in dire need of immediate solutions, said Valerie Sullivan, president and CEO of etectRx. Our goal for this collaboration is to bring concrete solutions to those who need it. ....

Corey Mccann , Caleb Liptak , Valerie Sullivan , Pear Therapeutics Inc , Cvrx Inc , Software Precertification Pilot Program , Pear Therapeutics , Central Nervous System , Prescription Digital Therapeutics , Cap System , Patient App , Clinician Dashboard , Precertification Pilot , கோரி ம்க்க்யாந் , காலேப் லிப்டக் , வலேரி சல்லிவன் , பேரிக்காய் சிகிச்சை இன்க் , ர்க்ஸ் இன்க் , பேரிக்காய் சிகிச்சை , மைய பதட்டமாக அமைப்பு , ப்ரிஸ்க்ரிப்ஶந் டிஜிட்டல் சிகிச்சை , தொப்பி அமைப்பு , நோயாளி செயலி , மருத்துவர் டாஷ்போர்டு ,

A look back at the how tech changed the pharma landscape in 2020


Share
The life science world has continued to deepen its interest in the digital space. While the mainstream life science news of the year was research on the coronavirus vaccine, when it came to digital the industries efforts were more varied. We saw new partnerships between pharma and digital health around topics such as respiration health, cardiovascular conditions and real-world data. 
This year we’ve also seen a number of new digital therapeutics on the market. In fact, in April the FDA released new guidance on digital health devices for treating psychiatric disorders that waives several regulatory requirements – such as the need to submit a 510(k) premarket notification – for the duration of the COVID-19 emergency. During this period we saw both Pear Therapeutics and Akili Interactive Labs take advantage of this early release.  ....

United Kingdom , United States , Enerzair Breezhaler , Otsuka Pharmaceuticals , Software Precertification Pilot Program , Oaktree Acquisition Corp , Propeller Health , Westport Office Park , Proteus Digital Health , Karolinsak Institute , Cincinnati Children Hospital Medical Center , Mcgill University , Pear Therapeutics , Akili Interactive Labs , Centaur Chemis , Firsthand Technology , Cincinnati Children , Hospital Medical Center , Sweden Based Karolinsak , Winterlight Labs , Office Park , Romanco North America , Otsuka America Pharmaceutical , Otsuka Pharmaceutical , Software Precertification Pilot , November Amazon ,